Y-20811 (sodium)
Y-20811 sodium is a selective and orally active thromboxane synthetase inhibitor. Y-20811 sodium can irreversibly inhibit thromboxane (TX) A2 synthesis. Y-20811 sodium can be used for the research of cardiovascular disease, such as thrombosis[1].
Product Specifications
CAS Number
104363-98-6
UNSPSC
12352005
Target
Prostaglandin Receptor
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O=C(C1=CC(C)=C(C(C2=CC(N3C=NC=C3)=CC=C2C)O)C(C)=C1)O[Na]
Molecular Formula
C20H19N2NaO3
Molecular Weight
358.37
References & Citations
[1]Mikashima H, et al. Irreversible inhibition of thromboxane (TX) A2 synthesis by Y-20811, a selective TX synthetase inhibitor. Biochem Pharmacol. 1992 Jan 22;43 (2) :295-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CAF07-S 1000000 Cells
Human Lung Squamous Cell Carcinoma Cancer-Associated Fibroblasts (CAFs)
Sign In for Pricing
View Details 
BNC472414-100 1x 100 µL
MDM2 (MDM2/2414), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details